Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Pharmacological Strategies for Duchenne Muscular Dystrophy
Shanshan Yao, Zihao Chen, Liang Yu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Functional abilities, respiratory and cardiac function in a large cohort of adults with Duchenne muscular dystrophy treated with glucocorticoids
Marianela Schiava, Robert Muni Lofra, John Bourke, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 6
Open Access | Times Cited: 6
Association between age at loss of ambulation and cardiac function in adults with Duchenne muscular dystrophy
Marianela Schiava, John Bourke, Jordi Díaz‐Manera, et al.
Neuromuscular Disorders (2025) Vol. 46, pp. 105276-105276
Closed Access
The latest developments in synthetic approaches to duchenne muscular dystrophy
Lucy M. Johnson, Tariq G. Pulskamp, Daniel J. Berlau
Expert Review of Neurotherapeutics (2025)
Closed Access
Role of Perinatal Stem Cell Secretome as Potential Therapy for Muscular Dystrophies
Serafina Pacilio, Sara Lombardi, Roberta Costa, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 458-458
Open Access
Extracellular vesicles and Duchenne muscular dystrophy pathology: Modulators of disease progression
Laura Yedigaryan, Maurilio Sampaolesi
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 11
The complex landscape of DMD mutations: moving towards personalized medicine
Francesca Gatto, Silvia Benemei, Giulio Piluso, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 3
Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers.
Margit Zweyer, Hemmen Sabir, Paul Dowling, et al.
PubMed (2022) Vol. 37, Iss. 2, pp. 101-116
Closed Access | Times Cited: 19
The metabolomic plasma profile of patients with Duchenne muscular dystrophy: providing new evidence for its pathogenesis
Huayan Xu, Xiaotang Cai, Ke Xu, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 10
Caveolin and NOS in the Development of Muscular Dystrophy
Moeka Nakashima, Naoko Suga, Sayuri Yoshikawa, et al.
(2024)
Open Access | Times Cited: 2
Orphan drugs’ clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement
Hans‐Georg Eichler, Michael Kossmeier, Markus Zeitlinger, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Phenotypic features of dystrophin gene knockout pigs harboring a human artificial chromosome containing the entire dystrophin gene
Watanabe Masahito, Hitomaru Miyamoto, Kazutoshi Okamoto, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 33, pp. 444-453
Open Access | Times Cited: 6
The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle
Nicolas Dubuisson, Romain Versele, María A. Davis‐López de Carrizosa, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2101-2101
Open Access | Times Cited: 6
Assessment of Motor Unit Potentials Duration as the Biomarker of DT-DEC01 Cell Therapy Efficacy in Duchenne Muscular Dystrophy Patients up to 12 Months After Systemic–Intraosseous Administration
Adam Niezgoda, Grzegorz Biegański, Jacek Wachowiak, et al.
Archivum Immunologiae et Therapiae Experimentalis (2023) Vol. 71, Iss. 1
Open Access | Times Cited: 6
Development of Therapeutic RNA Manipulation for Muscular Dystrophy
Saifullah Saifullah, Norio Motohashi, Toshifumi Tsukahara, et al.
Frontiers in Genome Editing (2022) Vol. 4
Open Access | Times Cited: 10
Patient-led development of digital endpoints and the use of computer vision analysis in assessment of motor function in rare diseases
Elisa Ferrer-Mallol, Clare Matthews, Madeline Stoodley, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy
Maura Argenziano, Vincenzo Pota, Alessandra Di Paola, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3345-3345
Open Access | Times Cited: 5
MyoD-induced reprogramming of human fibroblasts and urinary stem cells in vitro: protocols and their applications
Rachele Rossi, Silvia Torelli, Pierpaolo Ala, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 5
Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy
Breanne Maloney, Sunju Park, Mycroft Sowizral, et al.
Clinical Biochemistry (2023) Vol. 118, pp. 110614-110614
Open Access | Times Cited: 5
Rare paediatric disorders in Indian healthcare settings with focus on neuromuscular disorders: Diagnostic and management challenges
Aakash Mahesan, Gautam Kamila, Sheffali Gulati
Journal of Biosciences (2024) Vol. 49, Iss. 1
Closed Access | Times Cited: 1
Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials
Craig M. McDonald, James Signorovitch, Eugenio Mercuri, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0304099-e0304099
Open Access | Times Cited: 1
Mustn1 in Skeletal Muscle: A Novel Regulator?
Charles J. Kim, Michael Hadjiargyrou
Genes (2024) Vol. 15, Iss. 7, pp. 829-829
Open Access | Times Cited: 1
Systemic Treatment of Body‐Wide Duchenne Muscular Dystrophy Symptoms
Patryk Konieczny
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 6, pp. 1472-1484
Open Access | Times Cited: 1
Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy
Lakshmi Krishna, Akila Prashant, Yogish H. Kumar, et al.
Neurology International (2024) Vol. 16, Iss. 4, pp. 731-760
Open Access | Times Cited: 1
Muscular Dystrophies: An Update Review
Devarakonda Shalini, Jahangir Alam
International Journal of Innovative Science and Research Technology (IJISRT) (2024), pp. 3634-3639
Open Access | Times Cited: 1
Caveolin and NOS in the Development of Muscular Dystrophy
Moeka Nakashima, Naoko Suga, Sayuri Yoshikawa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8771-8771
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top